unknown
Stage
About
Allakos, Inc. is a clinical-stage biopharmaceutical company developing antibodies targeting receptor molecules on immune effector cells involved in allergy, inflammation, tissue damage, and proliferative disorders.
Explore Allakos, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.